1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl-

Request For Quotation
1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl- Suppliers list
Company Name: Guangzhou Brand-new Changshi Pharmaceutical Biotechnology Co., Ltd  Gold
Tel: 19066311943
Email: 815989315@qq.com
Company Name: Suzhou Meidi Senuo Pharmaceutical Technology Co., Ltd.  Gold
Tel: 13771642864
Email: snhuyu_2008@126.com
Company Name: Elucigen bio  Gold
Tel: 13501719342 13501719342
Email: wayne.zheng@elucigenbio.com
Company Name: Wuhan HSN Pharmaresearch CO., LTD.  Gold
Tel: 027-81525288 18086100502
Email: linwell@126.com
Company Name: Zhengzhou Runkai Pharmaceutical Technology Co., Ltd  Gold
Tel: 19137644811
Email: 3649307081@qq.com

1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl- manufacturers

  • Aficamten
  • Aficamten pictures
  • $68.00
  • 2026-07-17
  • CAS:2364554-48-1
  • Purity: 99.57%
  • Supply Ability: 10g
1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl- Basic information
Product Name:1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl-
Synonyms:1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl-;Aficamten (CK-3773274;CK3773274,CK-3773274,cardiac,CK-274,Myosin,cardiomyopathy,Inhibitor,CK 3773274,CK 274,hypertrophic,inhibit,Aficamten,CK274,HCM;Aficamten(CK274);Aficamten, 10 mM in DMSO;Aficamten (CK-274) ，E1016;Afkeitai;(R)-N-(5-(5-Ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-1-methyl-1H-pyrazole-4-carboxamide
CAS:2364554-48-1
MF:C18H19N5O2
MW:337.38
EINECS:
Product Categories:Aficamten
Mol File:2364554-48-1.mol
1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl- Structure
1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl- Chemical Properties
density 1.40±0.1 g/cm3(Predicted)
solubility DMSO : 125 mg/mL (370.50 mM; Need ultrasonic)
form A crystalline solid
pka13.84±0.20(Predicted)
color White to light brown
InChIInChI=1S/C18H19N5O2/c1-3-16-21-17(22-25-16)12-4-6-14-11(8-12)5-7-15(14)20-18(24)13-9-19-23(2)10-13/h4,6,8-10,15H,3,5,7H2,1-2H3,(H,20,24)/t15-/m1/s1
InChIKeyIOVAZWDIRCRMTM-OAHLLOKOSA-N
SMILESN1(C)C=C(C(N[C@H]2C3=C(C=C(C4N=C(CC)ON=4)C=C3)CC2)=O)C=N1
Safety Information
MSDS Information
1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl- Usage And Synthesis
UsesAficamten can be useful in the study of myosin modulation in cardiovascular medicine.
in vivo

Aficamten is a next-generation cardiac myosin inhibitor that provides a projected human half-life appropriate for once a day dosing, reaching steady state within two weeks, and demonstrates a wide therapeutic window in vivo with a clear PK/PD relationship[1].
Aficamten exhibits moderate oral bioavailability (mouse 98%, rat 55%, rat 58%,rat 79%, dog 45%, monkey 41%) following oral administration (mouse 1 mg/kg, rat 2 mg/kg, rat 3 mg/kg, rat 8 mg/kg, dog 1 mg/kg and monkey 1 mg/kg)[1].
Aficamten exhibits terminal elimination half-lives (mouse 4.5 h, rat 3.0 h, dog 33.8 h and, monkey 8.1 h) following intravenous administration (mouse 0.5 mg/kg, rat 1 mg/kg, dog 1 mg/kg and monkey 1.0 mg/kg)[1].

1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl- Preparation Products And Raw materials
Tag:1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl-(2364554-48-1) Related Product Information
1H-Pyrazole-4-carboxamide, N-[(1R)-5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl]-1-methyl- GITOXIN Mavacamten DIGOXIN 3β,5,14-Trihydroxy-5β-bufa-20,22-dienolide DIGITOXIGENIN